Inventor
ALEXANDRE JOSEPH BUCKMELTER
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes25%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
12,049,466Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors202412,043,623Purinones as ubiquitin-specific protease 1 inhibitors202412,018,030Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors202411,795,171Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors202311,739,071Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors202311,247,987Inhibiting ubiquitin specific peptidase 30202211,161,848Purinones as ubiquitin-specific protease 1 inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to FORMA THERAPEUTICS INC (4)· patent assignee history
2021–2024Based in US· patent location history
2023–2024Patents assigned to VALO HEALTH INC (3)· patent assignee history
2023Patents assigned to VALO EARLY DISCOVERY INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FORMA THERAPEUTICS INC | 4 | 2021–2024 |
| VALO HEALTH INC | 3 | 2023–2024 |
| VALO EARLY DISCOVERY INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2024 |